Key result
Advanced MRI outperforms traditional measures in quantifying microscopic neuronal damage in multiple sclerosis.
Why the study?
Traditional MRI measures for multiple sclerosis do not accurately correlate with neurological progression and physical disability, creating a need for alternative MRI metrics that better monitor clinical disease activity and treatment efficacy.
Do advanced MRI measures provide more accurate surrogate markers for neuronal injury and repair in multiple sclerosis compared to traditional MRI?
Do advanced MRI measures provide more accurate surrogate markers for neuronal injury and repair in multiple sclerosis compared to traditional MRI?
Advanced MRI metrics offer more sensitive quantification of neuronal damage in multiple sclerosis, potentially serving as better surrogate markers for evaluating disease-modifying therapies than traditional MRI.
No takes yet. Share an insight, caveat, or question.
May refine surrogate endpoints in MS trials; leaves open prospective validation against clinical outcomes.
Robert Zivadinov (2009) conducted a review in Multiple sclerosis. Advanced magnetic resonance imaging metrics vs. Traditional MRI measures was evaluated. Advanced MRI measures allow more sensitive quantification of microscopic neuronal damage and serve as more reliable surrogate markers for neuronal injury and repair in multiple sclerosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: